NDC 26637-643 - Amoxicillin Trihydrate and Clavulanate Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 26637-643
- Package NDCs from labels
- 26637-643-11
- Manufacturer
- Putney, Inc.
- Effective date
- 2020-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin Trihydrate and Clavulanate Potassium - Putney, Inc. | Putney, Inc. | 2020-01-24 | PRESCRIPTION ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 618953a3-0256-42ce-9155-d35325f017aa | 2026-03-02 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 56fb634c-3725-4d0a-8f20-584652a1d99f | 2026-03-02 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 30446852-9a54-4d16-ba12-56ffd0149985 | 2026-02-27 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | d213685c-5e67-4130-b00b-7626685dfa16 | 2026-02-26 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 6a078e7d-f942-4185-a131-50215d8e0a1e | 2026-02-25 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 3f9beabd-b579-460a-8ceb-789389b109f8 | 2026-02-20 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 77126eee-9534-4e80-9d11-ec78ec66c826 | 2026-02-19 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | bcd19a89-e9dc-b85f-e053-2a95a90a6f3e | 2026-02-19 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | f229e8b4-7045-4c0d-9214-890c0bda3c2a | 2026-02-16 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | a3d1c0bb-94f3-4cfb-a4c6-233cf7e519a4 | 2026-02-13 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2a376d67-0bf2-43a1-8ca3-73f90689c339 | 2026-02-06 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 94b7c1bb-c024-4dc6-86d4-18a17a3eafcb | 2026-02-04 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 776da91b-0626-1090-e053-2a91aa0a40f0 | 2026-01-28 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 16915fe9-1ac9-4ebb-afc8-eeb89144f30c | 2026-01-20 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | da5bfc31-5431-49b4-b21b-619712ab43a7 | 2026-01-13 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 48356a07-60b9-c844-e063-6394a90afafa | 2026-01-12 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | f433611c-db72-af7f-e053-2995a90a4a70 | 2026-01-05 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Redpharm Drug | 2fbb57ba-08d8-0224-e063-6294a90ab683 | 2025-12-30 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | ebf49514-0bce-ac56-e053-2a95a90ae540 | 2025-12-22 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | ccb8bfb1-1303-4c2d-9106-78684e6b859f | 2025-12-19 | Warnings, Adverse reactions | Q42OMW3AT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.